1253 Results

People

  1. Motzer
    Motzer
  2. Kingham
    Kingham
  3. Hudis
    Hudis
  4. Abou-Alfa
    Abou-Alfa
  5. Horwitz
    Horwitz
  6. Zelenetz
    Zelenetz
  7. Kris
    Kris
  8. Perales
    Perales
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)
  7. Population Sciences Research Program (170)
  8. Epidemiology and Biostatistics (122)
  9. Center for Pancreatic Cancer Research (110)
  10. Genitourinary Oncology Service (109)
  1. "multicenter study"
Formats
  1. Journal Article (1219)
  2. Research Letter (12)
  3. Conference Paper (7)
  4. Correspondence (6)
  5. Review (5)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)

More Groups

People
  1. Robert Motzer (47)
  2. T Peter Kingham (31)
  3. Clifford Hudis (19)
  4. Andrew Zelenetz (18)
  5. Ghassan Abou-Alfa (18)
  6. Steven Horwitz (18)

More People

Years
  1. 2025 (86)
  2. 2024 (191)
  3. 2023 (130)
  4. 2022 (83)
  5. 2021 (50)
  6. 2020 (63)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Lancet Oncology (57)
  3. New England Journal of Medicine (56)
  4. Clinical Cancer Research (46)
  5. Blood (44)
  6. Cancer (36)

More Publications

Publishers
  1. Elsevier Inc. (152)
  2. Elsevier Science, Inc. (137)
  3. American Society of Clinical Oncology (124)
  4. Springer (84)
  5. Oxford University Press (79)
  6. Wiley Blackwell (71)

More Publishers

Results (1253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
    Journal Article

    Lewis, K. D.; Peris, K.; Sekulic, A.; Stratigos, A. J.; Dunn, L.; Eroglu, Z.; Chang, A. L. S.; Migden, M. R.; Yoo, S. Y.; Mohan, K.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Recommended resting-state fMRI acquisition and preprocessing steps for preoperative mapping of language and motor and visual areas in adult and pediatric patients with brain tumors and epilepsy
    Journal Article

    Kumar, V. A.; Lee, J.; Liu, H. L.; Allen, J. W.; Filippi, C. G.; Holodny, A. I.; Hsu, K.; Jain, R.; McAndrews, M. P.; Peck, K. K.; more...
    American Journal of Neuroradiology (2024)

    Fulltext@MSK | Save
  • Posttransplantation late complications increase over time for patients with SCID: A primary immune deficiency treatment consortium (PIDTC) landmark study
    Journal Article

    Eissa, H.; Thakar, M. S.; Shah, A. J.; Logan, B. R.; Griffith, L. M.; Dong, H.; Parrott, R. E.; O'Reilly, R. J.; Dara, J.; Kapoor, N.; more...
    Journal of Allergy and Clinical Immunology (2024)

    Fulltext@MSK | Save
  • Multicenter phase 1b/2a clinical trial of radioprotectant BIO 300 oral suspension for patients with non-small cell lung cancer receiving concurrent chemoradiotherapy
    Journal Article

    Simone, C. B. 2nd; Serebrenik, A. A.; Gore, E. M.; Mohindra, P.; Brown, S. L.; Wang, D.; Chetty, I. J.; Vujaskovic, Z.; Menon, S.; Thompson, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Progression-free survival of daratumumab versus bortezomib triplet combination with lenalidomide and dexamethasone in transplant ineligible patients with newly diagnosed multiple myeloma: TAURUS chart review study
    Journal Article

    Gordan, L. N.; Tan, C. R.; Vescio, R.; Ye, J. C.; Schinke, C.; Medhekar, R.; Fu, A. Z.; Lafeuille, M. H.; Thompson-Leduc, P.; Khare, V.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
    Journal Article

    Zhao, J. L.; Antonarakis, E. S.; Cheng, H. H.; George, D. J.; Aggarwal, R.; Riedel, E.; Sumiyoshi, T.; Schonhoft, J. D.; Anderson, A.; Mao, N.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Sharon, E.; Park, S.; Ramaswamy, R.; Roe, C. E.; Irish, J. M.; Caldwell, A.; Wei, W.; Yacoub, A.; more...
    Annals of Hematology (2024)

    Fulltext@MSK | Save
  • A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
    Journal Article

    Lin, C. C.; Garralda, E.; Schöffski, P.; Hong, D. S.; Siu, L. L.; Martin, M.; Maur, M.; Hui, R.; Soo, R. A.; Chiu, J.; more...
    OncoImmunology (2024)

    Fulltext@MSK | Save
  • Automated preoperative and postoperative volume estimates risk of retreatment in chronic subdural hematoma: A retrospective, multicenter study
    Journal Article

    Vargas, J.; Pease, M.; Harrison Snyder, M.; Blalock, J.; Wu, S.; Nwachuku, E.; Mittal, A.; Okonkwo, D. O.; Kellogg, R. T.
    Neurosurgery (2024)

    Fulltext@MSK | Save
  • Repotrectinib in ROS1 fusion-positive non-small-cell lung cancer
    Journal Article

    Drilon, A.; Camidge, D. R.; Lin, J. J.; Kim, S. W.; Solomon, B. J.; Dziadziuszko, R.; Besse, B.; Goto, K.; de Langen, A. J.; Wolf, J.; more...
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save